Zimberelimab Clinical Trials
15 recruitingDrug
Phase 210Phase 16Phase 31
Showing 1–15 of 15 trials
Recruiting
Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Solid TumorsClear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.362 enrolled29 locationsNCT05536141
Recruiting
Phase 2
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Renal Cell CarcinomaKidney CancerRenal Carcinoma+1 more
Dana-Farber Cancer Institute32 enrolled3 locationsNCT07397611
Recruiting
Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Metastatic Urothelial Cancer
Gilead Sciences827 enrolled135 locationsNCT03547973
Recruiting
Phase 1
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
NeoplasmCancer, Malignant Tumors
Compugen Ltd200 enrolled11 locationsNCT06759649
Recruiting
Phase 2
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Gulam Manji60 enrolled5 locationsNCT06048484
Recruiting
Phase 2
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
CholangiocarcinomaBile Duct CancerBiliary Tract Carcinoma
Nataliya Uboha33 enrolled4 locationsNCT06048133
Recruiting
Phase 1Phase 2
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center56 enrolled1 locationNCT05688215
Recruiting
Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Gilead Sciences416 enrolled26 locationsNCT05007782
Recruiting
Phase 1Phase 2
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute31 enrolled1 locationNCT06238921
Recruiting
Phase 2
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
Catherine Spina23 enrolled1 locationNCT05915442
Recruiting
Phase 1
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Advanced Solid Tumors
Gilead Sciences154 enrolled6 locationsNCT06532565
Recruiting
Phase 2
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
Melanoma
Diwakar Davar26 enrolled1 locationNCT05130177
Recruiting
Phase 3
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Lung Diseases
Fundación GECP129 enrolled30 locationsNCT06431633
Recruiting
Phase 2
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
RemeGen Co., Ltd.116 enrolled12 locationsNCT06155396
Recruiting
Phase 2
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Locally Advanced Cervical Cancer
Tang-Du Hospital20 enrolled1 locationNCT06055738